Moshe Arkin, Insider at Orexigen Therapeutics, Inc. (OREX), sold 260,000 shares at $4.15 ($1.2M) on 2010-07-12, disclosed to the SEC on 2010-08-16.
Open-market sale of $1.2M OREX by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.15 | 20,000 | $83K | 6.7% |
| 2 | $4.15 | 135,000 | $560K | 45.3% |
| 3 | $5.64 | 105,000 | $592K | 47.9% |
| Total | $4.75 avg | 260,000 | $1.2M | 100% |
| Filing → |
| PRGO | SELL | 2011-09-02 | $7.6M | — | Filing → |
| PRGO | SELL | 2011-09-01 | $16.4M | — | Filing → |
| NGSX | SELL | 2011-06-28 | $18K | — | Filing → |